EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Tumor host relations 1. increased plasma cortisol in tumor bearing humans compared with patients with benign surgical disease



Tumor host relations 1. increased plasma cortisol in tumor bearing humans compared with patients with benign surgical disease



Journal of Cancer Research and Clinical Oncology 93(3): 281-286



Plasma cortisol was measured by a protein binding technique in 81 patients with malignant tumors of different extent and various sites and in 82 patients with benign surgical diseases. The mean value of the tumor patients (.hivin.x .+-. s = 165 .+-. 69 .mu.g cortisol/l plasma) was increased significantly compared with the benign surgical disorders (100 .+-. 45 .mu.g/l). Within the group of patients with benign surgical disorders there was little variation by the type of disease (cortisol mean values given in brackets): benign breast tumors (95), gall stones (107), ulcer of the stomach and duodenum (96), hernia (78), appendicitis acuta (112) and struma (90). The results are in accordance with the hypothesis that glucocorticoids are involved in the increased protein catabolism of skeletal muscles and other signs of cachectic tumor patients.

(PDF 0-2 workdays service: $29.90)

Accession: 006846849

Download citation: RISBibTeXText

PMID: 468889



Related references

Tumor host relations 2. influence of tumor extent and tumor site on plasma cortisol of patients with malignant diseases. Journal of Cancer Research and Clinical Oncology 93(3): 287-292, 1979

Tumor host relations 6. is alpha keto glutarate a tumor marker association with tumor extent in humans correlation with tumor size in rats. Journal of Cancer Research and Clinical Oncology 97(3): 295-300, 1980

A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones 4(4): 226-230, 2006

Deregulation of plasma proteinase activity in tumor bearing animals is the result of the host response to the tumor. Journal of Cellular Biochemistry Supplement (10 PART A): 249, 1986

Tumor host relations 4. tissue distribution of citric acid cycle intermediates and of glutamate in tumor bearing rats high level of alpha keto glutarate in solid yoshida sarcomas. Journal of Cancer Research and Clinical Oncology 97(2): 137-144, 1980

Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Romanian Journal of Morphology and Embryology 52(4): 1261-1267, 2012

High tumor-preventive effects of polyclonal IgG generated against p53 tumor-associated protein obtained from benign-tumor bearing rats. Oncology Reports 3(5): 975-979, 1996

Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro. Proceedings of the National Academy of Sciences of the United States of America 72(12): 5086-5089, 1975

Analysis of alteration of host immunoreactivity associated with tumor bearing and its effect on lymphokine activated killer cells in a tumor bearing rat model. Sapporo Medical Journal 60(2): 215-229, 1991

The immune status of tumor bearing host part 1 observations on the dynamics of the spleen hemolytic plaque forming cells in several strains of tumor bearing mice. Acta Zoologica Sinica 21(4): 309-318, 1975

Effects of total parenteral nutrition on tumor growth and plasma and tumor free amino acids in tumor bearing rats. Okayama Igakkai Zasshi 94(9-10): 853-876, 1983